The abnormal expression of TNFAIP2 has been identified in various malignant tumors, involved in unlimited proliferation, angiogenesis, and migration, including urothelial cancer, esophageal squamous cell carcinoma, and nasopharyngeal carcinoma (39–42). This evidence concerns the gene TNFAIP2 and cancer.